FDA
-
-
-
-
-
-
-
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
-
-
-
-
-
-
-
Vivos Therapeutics reports 70% revenue growth in first quarter
-
-
-
-
-
-
-
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
-
-
-
-
-
-
-
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies
-
-
-
-
-
-
-
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
-
-
-
-
-
-
-
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Vivos Therapeutics (VVOS) highlights positive trial results for treatment of OSA with Daytime-Nighttime Appliance
-
327,805 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

